Literature DB >> 36104207

What Is the Optimal Surrogate Indicator for a Miss Rate of Adenoma in Colonoscopy?

Seung Wook Hong1, Jeong-Sik Byeon1.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 36104207      PMCID: PMC9474491          DOI: 10.5009/gnl220365

Source DB:  PubMed          Journal:  Gut Liver        ISSN: 1976-2283            Impact factor:   4.321


× No keyword cloud information.
It is well established that the incidence of colorectal cancer (CRC) and CRC-related mortality can be reduced by screening colonoscopy with polypectomy for an adenoma, which is a precancerous lesion of CRC.1,2 Based on these evidences, nationwide colonoscopy volume is steadily increasing.3 However, the quality of a colonoscopy can be different depending on various factors, including the endoscopist’s proficiency, adequate bowel preparation, and colonoscopy withdrawal time. Therefore, it is crucial to develop indicators to evaluate and monitor them. The adenoma detection rate (ADR) is the primary indicator of colonoscopy quality, which is defined as the proportion of screening cololonoscopies performed by an endoscopist that detected one or more adenomas. Corley et al.4 conducted a multicenter study in 2014 that analyzed 314,872 colonoscopies performed by 136 endoscopists and found that ADR was inversely related to the risk of interval CRC. Given on this and subsequent studies, the U.S. Multi-Society Task Force guideline recommends an adequate ADR for asymptomatic individuals aged 50 years or older should be greater than 30% in men and greater than 20% in women.5 High ADR is considered to be significant in evaluating the colonoscopy quality, but there is a limitation that the ADR does not reflect the overall quality of the colonoscopy. The ADR is an indicator that cannot reflect missed adenomas in individuals with two or more adenomas. Considering that one of the major causes of interval CRC is a missed lesion, another colonoscopy quality indicator that can reflect a missed adenoma is warranted. In 2016, four endoscopists performed back-to-back colonoscopies for 200 participants, showing a significant difference in the adenoma miss rate (AMR) even among endoscopists with high ADR.6 Since back-to-back colonoscopy is inevitably required to determine the AMR, it is warranted to explore other colonoscopy indicators correlated with AMR. Han et al.7 conducted a prospective multicenter study, which performed back-to-back colonoscopy to investigate the correlation between the AMR and other colonoscopy parameters including ADR, polyp detection rate, total number of adenomas per colonoscopy, additional adenomas found after the first adenoma per colonoscopy, and total number of adenomas per positive participant (APP). A total of eight endoscopists participated in this study. All endoscopists showed a high ADR (>40%), but the AMR varied from 8.8% to 28.6%, which reminds us again that a high ADR does not guarantee a low AMR. None of the colonoscopy indicators were significantly associated with the AMR.7 The logistic regression analysis revealed that the probability of missed polyp increased significantly as the number of adenomas increased during the first colonoscopy.7 Therefore, we should be aware the AMR in patients with multiple adenomas may be high. In previous studies, there have been attempts to explore a surrogate indicator for AMR. The study by Aniwan et al.6 showed that the APP was inversely correlated with AMR (r=–0.99, p<0.01). In addition, a meta-analysis with 43 studies also found that APP was independently associated with AMR (p=0.008).8 Given these results, APP has drawn attention as a surrogate indicator for AMR. However, the study by Han et al.7 showed inconsistent results with previous studies. The authors of this study stated the cause of this discrepancy as heterogeneity among the participants.7 Considering the intrinsic limitation of clinical studies related to colorectal polyps, in addition to the participant’s heterogeneity pointed out by the author, various factors, including the endoscopist’s own characteristics and equipment in each institution, which are related to adenoma detection, might have caused this discrepancy. Eventually, the optimal surrogate indicator of AMR should be addressed through subsequent studies. ADR represents the ability to distinguish the presence from the absence of adenomas in all colonoscopies, whereas AMR represents the ability to distinguish the magnitude of adenomas which may compensate for ADR's weakness. Thus, not only ADR but also AMR should be considered for qualified colonoscopy. An optimal surrogate indicator of AMR without back-to-back colonoscopy should fulfill the following conditions: (1) have a high correlation with AMR; (2) be simple to calculate on a single colonoscopy; (3) derive reliable results from a qualified colonoscopy; and (4) propose a validated cutoff value. Despite efforts of many researchers, a good surrogate quality indicator that can reflect AMR adequately has not been established to date. It is necessary for large-scale subsequent studies with well-controlled confounders related to adenoma detection to elucidate which surrogate indicators of AMR are optimal. Given the clinical significance of missed adenoma, we should continuously explore a reliable surrogate indicator reflecting it and seek ways to reduce it.9,10 We look forward to the subsequent studies regarding missed adenoma or AMR in colonoscopy.
  10 in total

1.  Magnitude, Risk Factors, and Factors Associated With Adenoma Miss Rate of Tandem Colonoscopy: A Systematic Review and Meta-analysis.

Authors:  Shengbing Zhao; Shuling Wang; Peng Pan; Tian Xia; Xin Chang; Xia Yang; Liliangzi Guo; Qianqian Meng; Fan Yang; Wei Qian; Zhichao Xu; Yuanqiong Wang; Zhijie Wang; Lun Gu; Rundong Wang; Fangzhou Jia; Jun Yao; Zhaoshen Li; Yu Bai
Journal:  Gastroenterology       Date:  2019-02-06       Impact factor: 22.682

Review 2.  New technologies improve adenoma detection rate, adenoma miss rate, and polyp detection rate: a systematic review and meta-analysis.

Authors:  Daniel Castaneda; Violeta B Popov; Elijah Verheyen; Praneet Wander; Seth A Gross
Journal:  Gastrointest Endosc       Date:  2018-04-01       Impact factor: 9.427

Review 3.  Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer.

Authors:  Douglas K Rex; C Richard Boland; Jason A Dominitz; Francis M Giardiello; David A Johnson; Tonya Kaltenbach; Theodore R Levin; David Lieberman; Douglas J Robertson
Journal:  Am J Gastroenterol       Date:  2017-06-06       Impact factor: 10.864

4.  Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths.

Authors:  Ann G Zauber; Sidney J Winawer; Michael J O'Brien; Iris Lansdorp-Vogelaar; Marjolein van Ballegooijen; Benjamin F Hankey; Weiji Shi; John H Bond; Melvin Schapiro; Joel F Panish; Edward T Stewart; Jerome D Waye
Journal:  N Engl J Med       Date:  2012-02-23       Impact factor: 91.245

5.  Impact of Artificial Intelligence on Miss Rate of Colorectal Neoplasia.

Authors:  Michael B Wallace; Prateek Sharma; Pradeep Bhandari; James East; Giulio Antonelli; Roberto Lorenzetti; Micheal Vieth; Ilaria Speranza; Marco Spadaccini; Madhav Desai; Frank J Lukens; Genci Babameto; Daisy Batista; Davinder Singh; William Palmer; Francisco Ramirez; Rebecca Palmer; Tisha Lunsford; Kevin Ruff; Elizabeth Bird-Liebermann; Victor Ciofoaia; Sophie Arndtz; David Cangemi; Kirsty Puddick; Gregory Derfus; Amitpal S Johal; Mohammed Barawi; Luigi Longo; Luigi Moro; Alessandro Repici; Cesare Hassan
Journal:  Gastroenterology       Date:  2022-03-15       Impact factor: 33.883

6.  The Secondary Quality Indicator to Improve Prediction of Adenoma Miss Rate Apart from Adenoma Detection Rate.

Authors:  Satimai Aniwan; Piyachai Orkoonsawat; Vichai Viriyautsahakul; Phonthep Angsuwatcharakon; Rapat Pittayanon; Naruemon Wisedopas; Sakolkun Sumdin; Yuwadee Ponuthai; Sumitra Wiangngoen; Pinit Kullavanijaya; Rungsun Rerknimitr
Journal:  Am J Gastroenterol       Date:  2016-01-26       Impact factor: 10.864

7.  Adenoma detection rate and risk of colorectal cancer and death.

Authors:  Douglas A Corley; Christopher D Jensen; Amy R Marks; Wei K Zhao; Jeffrey K Lee; Chyke A Doubeni; Ann G Zauber; Jolanda de Boer; Bruce H Fireman; Joanne E Schottinger; Virginia P Quinn; Nirupa R Ghai; Theodore R Levin; Charles P Quesenberry
Journal:  N Engl J Med       Date:  2014-04-03       Impact factor: 91.245

8.  Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.

Authors:  S J Winawer; A G Zauber; M N Ho; M J O'Brien; L S Gottlieb; S S Sternberg; J D Waye; M Schapiro; J H Bond; J F Panish
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

9.  Real-World National Colonoscopy Volume in Korea: A Nationwide Population-Based Study over 12 Years.

Authors:  Jae Myung Cha; Min Seob Kwak; Hyun-Soo Kim; Su Young Kim; Sohee Park; Geun U Park; Jung Kuk Lee; Soo Jin Kim; Hun Hee Lee; Joo Sung Kim; Won Ho Kim
Journal:  Gut Liver       Date:  2020-05-15       Impact factor: 4.519

10.  Correlation between Surrogate Quality Indicators for Adenoma Detection Rate and Adenoma Miss Rate in Qualified Colonoscopy, CORE Study: KASID Multicenter Study.

Authors:  Jae Hee Han; Hyun Gun Kim; Eu Mi Ahn; Suyeon Park; Seong Ran Jeon; Jae Myung Cha; Min Seob Kwak; Yunho Jung; Jeong Eun Shin; Hyun Deok Shin; Young-Seok Cho
Journal:  Gut Liver       Date:  2021-12-21       Impact factor: 4.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.